Staphylococcus aureus skin infection recurrences among household members: An examination of host, behavioral, and pathogen-level predictors

Clinical Infectious Diseases

Volumn 60, Issue 5, 2015, Pages 753-763

  Miller, Loren G ^a   Eells, Samantha J ^a   David, Michael Z ^b   Ortiz, Nancy ^a   Taylor, Alexis R ^b   Kumar, Neha ^b   Cruz, Denise ^a   Boyle Vavra, Susan ^b   Daum, Robert S ^b  

^a UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Molecular typing; Outcomes; Predictors; Skin infection; Staphylococcus aureus

Indexed keywords

CEFALEXIN; CLINDAMYCIN; COTRIMOXAZOLE;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM EXAMINATION; CHILD; COMMUNITY ACQUIRED INFECTION; CONTACT SPORT; CONTROLLED STUDY; FEMALE; FOLLOW UP; FOMITE; HEALTHCARE ASSOCIATED INFECTION; HISPANIC; HOSPITALIZATION; HOST; HOUSEHOLD; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PREDICTION; PRIORITY JOURNAL; RECURRENT INFECTION; SKIN INFECTION; STAPHYLOCOCCUS INFECTION; UNITED STATES; ADOLESCENT; CALIFORNIA; CROSS-SECTIONAL STUDY; FAMILY SIZE; ILLINOIS; INFANT; ISOLATION AND PURIFICATION; LONGITUDINAL STUDY; MICROBIOLOGY; MIDDLE AGED; PRESCHOOL CHILD; PROSPECTIVE STUDY; RECURRENT DISEASE; RISK FACTOR; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHICAGO; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FAMILY CHARACTERISTICS; FEMALE; FOMITES; HUMANS; INFANT; LONGITUDINAL STUDIES; LOS ANGELES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS; YOUNG ADULT;

EID: 84928895314     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu943     Document Type: Article

References (52)

1. David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 2010; 23:616-87.
2. Mulligan ME, Murray-Leisure KA, Ribner BS, et al. Methicillinresistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med 1993; 94:313-28.
3. Fritz SA, Hogan PG, Hayek G, et al. Household versus individual approaches to eradication of community-associated Staphylococcus aureus in children: a randomized trial. Clin Infect Dis 2012; 54:743-51.
4. Miller LG, Quan C, Shay A, et al. A prospective investigation of outcomes after hospital discharge for endemic, community-acquired methicillin-resistant and-susceptible Staphylococcus aureus skin infection. Clin Infect Dis 2007; 44:483-92.
5. Crum-Cianflone N, Weekes J, Bavaro M. Recurrent communityassociated methicillin-resistant Staphylococcus aureus infections among HIV-infected persons: incidence and risk factors. AIDS Patient Care STDS 2009; 23:499-502.
6. Miller LG, Diep BA. Colonization, fomites, and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2008; 46:742-50.
7. Graber CJ, Jacobson MA, Perdreau-Remington F, Chambers HF, Diep BA. Recurrence of skin and soft tissue infection caused by methicillinresistant Staphylococcus aureus in a HIV primary care clinic. J Acquir Immune Defic Syndr 2008; 49:231-3.
8. Gorwitz RJ, Jernigan DB, Powers JH, Jernigan JA; participants in the CDC-convened Experts' Meeting on Management of MRSA in the Community. Strategies for clinical management of MRSA in the community: summary of an experts' meeting convened by the Centers for Disease Control and Prevention, 2006. Available at: http://www.cdc. gov/mrsa/pdf/MRSA-Strategies-ExpMtgSummary-2006.pdf. Accessed 8 December 2014.
9. Miller LG, Kaplan SL. Staphylococcus aureus: a community pathogen. Infect Dis Clin North Am 2009; 23:35-52.
10. Maree C, Daum RS, Boyle-Vavra S, Matayoshi K, Miller LG. Community-associated methicillin-resistant Staphylococcus aureus strains causing healthcare-associated infections. Emerg Infect Dis 2007; 13:236-42.
11. von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med 2001; 344:11-6.
12. Uhlemann AC, Knox J, Miller M, et al. The environment as an unrecognized reservoir for community-associated methicillin resistant Staphylococcus aureus USA300: a case-control study. PLoS One 2011; 6:e22407.
13. Roberts MC, Soge OO, No D, Helgeson SE, Meschke JS. Characterization of methicillin-resistant Staphylococcus aureus isolated from public surfaces on a university campus, student homes and local community. J Appl Microbiol 2011; 110:1531-7.
14. Scott E, Duty S, Callahan M. A pilot study to isolate Staphylococcus aureus and methicillin-resistant S aureus from environmental surfaces in the home. Am J Infect Control 2008; 36:458-60.
15. Desai R, Pannaraj PS, Agopian J, Sugar CA, Liu GY, Miller LG. Survival and transmission of community-associated methicillin-resistant Staphylococcus aureus from fomites. Am J Infect Control 2011; 39: 219-25.
16. Turabelidze G, Lin M, Wolkoff B, Dodson D, Gladbach S, Zhu BP. Personal hygiene and methicillin-resistant Staphylococcus aureus infection. Emerg Infect Dis 2006; 12:422-7.
17. Kazakova SV, Hageman JC, Matava M, et al. A clone of methicillinresistant Staphylococcus aureus among professional football players. N Engl J Med 2005; 352:468-75.
18. Joshi GS, Spontak JS, Klapper DG, Richardson AR. Arginine catabolic mobile element encoded speG abrogates the unique hypersensitivity of Staphylococcus aureus to exogenous polyamines. Mol Microbiol 2011; 82:9-20.
19. Miller LG, Eells SJ, Taylor AR, et al. Staphylococcus aureus colonization among household contacts of patients with skin infections: risk factors, strain discordance, and complex ecology. Clin Infect Dis 2012; 54:1523-35.
20. Miller LG, Perdreau-Remington F, Bayer AS, et al. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillinsusceptible S. aureus infection: a prospective investigation. Clin Infect Dis 2007; 44:471-82.
21. Yang ES, Tan J, Eells S, Rieg G, Tagudar G, Miller LG. Body site colonization prevalence in patients with community-associated methicillin-resistant Staphylococcus aureus and other forms of Staphylococcus aureus and skin infections. Clin Microbiol Infect 2010; 16:425-31.
22. Maree CM, Eells SJ, Tan J, et al. Risk factors for infection and colonization with community-associated methicillin-resistant Staphylococcus aureus in the Los Angeles County jail: a case control study. Clin Infect Dis 2010; 51:1248-57.
23. Graffunder EM, Venezia RA. Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother 2002; 49:999-1005.
24. Lee NE, Taylor MM, Bancroft E, et al. Risk factors for communityassociated methicillin-resistant Staphylococcus aureus skin infections among HIV-positive men who have sex with men. Clin Infect Dis 2005; 40:1529-34.
25. Centers for Disease Control and Prevention . Outbreaks of communityassociated methicillin-resistant Staphylococcus aureus skin infections- Los Angeles County, California, 2002-2003. MMWR Morb Mortal Wkly Rep 2003; 52:88.
26. Eady EA, Cove JH. Staphylococcal resistance revisited: communityacquired methicillin resistant Staphylococcus aureus-an emerging problem for the management of skin and soft tissue infections. Curr Opin Infect Dis 2003; 16:103-24.
27. Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 2001; 7:178-82.
28. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillinresistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 2003; 36:131-9.
29. Naimi TS, LeDell KH, Boxrud DJ, et al. Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998. Clin Infect Dis 2001; 33:990-6.
30. Shahin R, Johnson IL, Jamieson F, McGeer A, Tolkin J, Ford-Jones EL. Methicillin-resistant Staphylococcus aureus carriage in a child care center following a case of disease. Toronto Child Care Center Study Group. Arch Pediatr Adolesc Med 1999; 153:864-8.
31. McManus R. CDC's GerberdingWarns of Anti-Microbial-Resistant Infections. Available at: http://nihrecord.od.nih.gov/newsletters/03-02- 2004/story01.htm. Accessed 8 December 2014.
32. Baggett HC, Hennessy TW, Leman R, et al. An outbreak of communityonset methicillin-resistant Staphylococcus aureus skin infections in southwestern Alaska. Infect Control Hosp Epidemiol 2003; 24:397-402.
33. Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000; 38:1008-15.
34. International Working Group on the Classification of Staphylococcal Cassette Chromosome Elements (IWG-SCC). Classification of staphylococcal cassette chromosome mec (SCCmec): guidelines for reporting novel SCCmec elements. Antimicrob Agents Chemother 2009; 53:4961-7.
35. Boyle-Vavra S, Ereshefsky B, Wang CC, Daum RS. Successful multiresistant community-associated methicillin-resistant Staphylococcus aureus lineage from Taipei, Taiwan, that carries either the novel staphylococcal chromosome cassette mec (SCCmec) type VT or SCCmec type IV. J Clin Microbiol 2005; 43:4719-30.
36. Lina G, Piemont Y, Godail-Gamot F, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999; 29:1128-32.
37. David MZ, Taylor A, Lynfield R, et al. Comparing pulsed-field gel electrophoresis with multilocus sequence typing, spa typing, staphylococcal cassette chromosome mec (SCCmec) typing, and PCR for Panton-Valentine leukocidin, arcA, and opp3 in methicillin-resistant Staphylococcus aureus isolates at a U.S. medical center. J Clin Microbiol 2013; 51:814-9.
38. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373-83.
39. Minnesota Department of Health. Community-associated methicillinresistant Staphylococcus aureus in Minnesota. Minnesota Department of Health Disease Control Newsletter, 2004; 32:61-72.
40. Kleinbaum DG, Klein M. Logistic regression: a self-learning text. New York, NY: Springer, 2002.
41. Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus infections among competitive sports participants- Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003. MMWR Morb Mortal Wkly Rep 2003; 52:793-5.
42. Lindenmayer JM, Schoenfeld S, O'Grady R, Carney JK. Methicillinresistant Staphylococcus aureus in a high school wrestling team and the surrounding community. Arch Intern Med 1998; 158: 895-9.
43. Lu D, Holtom P. Community-acquired methicillin-resistant Staphylococcus aureus, a new player in sports medicine. Curr Sports Med Rep 2005; 4:265-70.
44. Centers for Disease Control and Prevention. MRSA information for coaches, athletic directors, and team healthcare providers. Available at: http://www.cdc.gov/mrsa/community/team-hc-providers/index. html. Accessed 10 June 2014.
45. StopMRSAnow.org. Your locker room or gym. Available at: http:// stopmrsanow.com/locker-room-or-gym.html. Accessed 8 December 2014.
46. Montgomery CP, Boyle-Vavra S, Adem PV, et al. Comparison of virulence in community-associated methicillin-resistant Staphylococcus aureus pulsotypes USA300 and USA400 in a rat model of pneumonia. J Infect Dis 2008; 198:561-70.
47. Miller LG, Tan J, Eells SJ, Benitez E, Radner AB. Prospective investigation of nasal mupirocin, hexachlorophene body wash, and systemic antibiotics for prevention of recurrent community-associated methicillin-resistant Staphylococcus aureus infections. Antimicrob Agents Chemother 2012; 56:1084-6.
48. Whitman TJ, Schlett CD, Grandits GA, et al. Chlorhexidine gluconate reduces transmission of methicillin-resistant Staphylococcus aureus USA300 among Marine recruits. Infect Control Hosp Epidemiol 2012; 33:809-16.
49. Barcikowski RS, Robey RR. Use and misuse of repeated measures designs. NIDA Res Monogr 1994; 142:302-41.
50. Como-Sabetti KJ, Harriman KH, Fridkin SK, Jawahir SL, Lynfield R. Risk factors for community-associated Staphylococcus aureus infections: results from parallel studies including methicillin-resistant and methicillin-sensitive S. aureus compared to uninfected controls. Epidemiol Infect 2011; 139:419-29.
51. Garbacz K, Piechowicz L, Baranska-Rybak W, Dabrowska-Szponar M. Staphylococcus aureus isolated from patients with recurrent furunculosis carrying Panton-Valentine leukocidin genes represent agr specificity group IV. Eur J Dermatol 2011; 21:43-6.
52. Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005; 352:1436-44.